More on SOLV

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+8.0% Growth)
- Ratings (5.3 Score)

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Solventum Corporation (NY:SOLV)
Delayed: 87.45 +0.78 (0.90%)
Prev. Close $86.67  
Open$86.89 
52 Wk High$ 
52 Wk Low$ 
Day High$87.87 
Day Low$86.42 
P/E N/A  
EPS$ 
Volume769,892 

Friends, Peers and Foes (?): SOLV.WI, TMO, ALC, ICUI, SHC (more...)

Oct 19, 2026 04:05 PM FDA clears Solventum's combined Restrata Matrix and V.A.C. Therapy
Oct 19, 2026 04:05 PM Solventum Announces FDA 510(k) Clearance for Combined Use of Restrata™ Matrix and Solventum™ V.A.C.® Therapy*
Oct 15, 2026 04:05 PM Solventum to Report Third Quarter Fiscal 2026 Earnings on November 5, 2026
Oct 8, 2026 06:09 AM Solventum (SOLV) PT Lowered to $34 at Jefferies
Oct 6, 2026 09:06 AM Wound Care Stocks Are Posting Double-Digit Growth. Here’s Why.
Sep 18, 2026 07:47 AM Solventum (SOLV) Reiterated at Buy by Stifel Amid SKU Growth Headwinds
Sep 3, 2026 04:11 PM Form 4 Solventum Corp For: Sep 01 Filed by: Hanson Bryan C
Sep 2, 2026 04:05 PM Solventum to Participate in the 2026 Wells Fargo Healthcare Conference
Aug 18, 2026 04:11 PM Form 4 Solventum Corp For: Aug 17 Filed by: Zieselman Neil Craig
Aug 18, 2026 04:09 PM Form 3 Solventum Corp For: Aug 10 Filed by: Zieselman Neil Craig
View All Articles

Entities mentioned with SOLV

View All Entities